BTS
NKTR icon

BB&T Securities’s Nektar Therapeutics NKTR Stock Holding History

BB&T Securities’s Portfolio NKTR Stock Details NKTR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q3 		– Sell
-531
Closed -$283K – 1672
2019
Q2 		$283K Buy
531
+65
+14% +$32.6K ﹤0.01% 1340
2019
Q1 		$234K Sell
466
-7
-1% -$4.15K ﹤0.01% 1421
2018
Q4 		$233K Sell
473
-292
-38% -$176K ﹤0.01% 1299
2018
Q3 		$698K Buy
765
+334
+77% +$285K 0.01% 945
2018
Q2 		$315K Buy
431
+164
+61% +$189K ﹤0.01% 1260
2018
Q1 		$425K Buy
+267
New +$344K ﹤0.01% 1090

Other funds holding NKTR

Invesco
Invesco Atlanta, Georgia $653B AUM 32.41% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return
CCM
Camber Capital Management Boston, Massachusetts $718M AUM 8.19% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return